Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Polyphor
Biotech
Spexis narrows focus to keep lights on into 2023
With the ink barely dry on the merger that created it, the Swiss biotech is narrowing focus to stretch its cash runway out to January 2023.
Nick Paul Taylor
Jul 28, 2022 8:45am
Polyphor to lay off staff, shutter failed breast cancer phase 3
Jul 16, 2021 8:15am
Polyphor flops a phase 3, jeopardizing its future
Jun 28, 2021 7:05am
Polyphor's breast cancer candidate shows promise in COVID-19
Jun 7, 2021 8:30am
Santhera, reeling from DMD blow, lands cystic fibrosis drug
Feb 15, 2018 8:50am
